ArticleFrontiers in nutrition2025
Nutritional management for a lung cancer patient receiving concurrent radiotherapy and immunotherapy and developing immune-related dermatitis: a case report.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Concurrent radiotherapy and immunotherapy is an alternative treatment regimen for elderly patients with locally advanced non-small cell lung cancer (NSCLC) who have contraindications to or decline surgery and chemotherapy. While these patients are susceptible to malnutrition and treatment-related adverse events, experience for their nutritional management is still lacking. In this case report, we summarized the nutritional management process for a NSCLC patient with severe malnutrition, who received concurrent radiotherapy and immunotherapy and developed immune-related dermatitis. Case summary: In March 2024, a 71-year-old male with lung squamous cell carcinoma and severe malnutrition was hospitalized in Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center. During concurrent radiotherapy and tislelizumab immunotherapy, the patient developed grade 2 radiation-induced esophagitis and grade 3 immune-related dermatitis. The medical team dynamically assessed the patient's nutritional status, set reasonable nutritional goals, and promptly adjusted nutritional prescriptions according to the severity and cause of the nutritional gap. Key measures included upgrading to combined enteral and parenteral nutrition support during radiation-induced esophagitis complicated by immune-related oral ulcers, adjusting the type of parenteral nutrition formulation for suspected lipid emulsion allergy, and strengthening immunonutrient supplementation during the dermatitis phase. Concurrently, progressive aerobic and resistance exercise training was guided to promote rehabilitation. Via the phased nutritional management, the patient's nutritional indicators significantly improved after 54 days of hospitalization. Anti-tumor treatment was successfully completed, and the dermatitis healed. Conclusion: For lung cancer patients complicated with immune-related dermatitis during concurrent radiotherapy and immunotherapy, whole-course management including phased adjustment of nutritional strategies, early differentiation of dermatitis, and integration with exercise rehabilitation may effectively improve nutritional status and promote dermatitis healing, thus supporting the completion of anti-cancer therapy. Further studies with larger sample sizes are required to confirm the effect of nutritional management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.